SURI
SURI
About Simplify Propel Opportunities ETF
The Simplify Propel Opportunities ETF (SURI) aims to deliver substantial long-term capital growth. It achieves this by investing in companies across the biotechnology, pharmaceutical, healthcare technology, and life sciences industries. These particular firms are selected because they are believed to be overlooked by investors, suggesting significant potential for their value to increase. Propel,...
About Simplify Propel Opportunities ETF
The Simplify Propel Opportunities ETF (SURI) aims to deliver substantial long-term capital growth. It achieves this by investing in companies across the biotechnology, pharmaceutical, healthcare technology, and life sciences industries. These particular firms are selected because they are believed to be overlooked by investors, suggesting significant potential for their value to increase. Propel,...
HOLDINGS (Top 20)
| Stock | Name | Weight | Shares | Market Value |
|---|---|---|---|---|
 PAGP | Plains GP Holdings LP | 41.33% | 1.27M | $32.20M |
 ACHV | Achieve Life Sciences, Inc. | 11.60% | 1.43M | $9.04M |
 MIST | Milestone Pharmaceuticals Inc. | 5.59% | 3.35M | $4.35M |
 DCTH | Delcath Systems, Inc. | 4.40% | 261.13K | $3.43M |
 PHAT | Phathom Pharmaceuticals, Inc. | 3.53% | 249.27K | $2.75M |
 CORT | Corcept Therapeutics Incorporated | 3.07% | 26.43K | $2.39M |
 CLDX | Celldex Therapeutics, Inc. | 2.60% | 53.13K | $2.03M |
 ABEO | Abeona Therapeutics Inc. | 2.50% | 276.33K | $1.95M |
 CMPS | COMPASS Pathways plc | 1.96% | 114.28K | $1.53M |
 KYTX | Kyverna Therapeutics, Inc. | 1.86% | 182.60K | $1.45M |
 LONA | LeonaBio, Inc. | 1.82% | 149.28K | $1.42M |
 IVA | Inventiva S.A. | 1.77% | 313.48K | $1.38M |
 AQST | Aquestive Therapeutics, Inc. | 1.45% | 278.72K | $1.13M |
 ARTV | Artiva Biotherapeutics, Inc. | 1.22% | 101.36K | $947.67K |
 ZVRA | Zevra Therapeutics, Inc. | 1.13% | 67.37K | $879.88K |
 PALI | Palisade Bio, Inc. | 1.08% | 434.33K | $838.26K |
 OBIO | Orchestra BioMed Holdings, Inc. | 1.04% | 219.39K | $809.54K |
 OCUL | Ocular Therapeutix, Inc. | 1.01% | 81.05K | $786.19K |
 EYPT | EyePoint Pharmaceuticals, Inc. | 0.68% | 38.60K | $529.95K |
 IMUX | Immunic, Inc. | 0.58% | 30.73K | $451.35K |
SECTOR HOLDINGS
Healthcare
EnergyASSET ALLOCATION BY REGION
United States
Canada
United Kingdom
FranceSECTOR HOLDINGS
Healthcare EnergyASSET ALLOCATION BY REGION
United States Canada United Kingdom FranceHoldings (Top 20)
PAGP
Plains GP Holdings LP
ACHV
Achieve Life Sciences, Inc.
MIST
Milestone Pharmaceuticals Inc.
DCTH
Delcath Systems, Inc.
PHAT
Phathom Pharmaceuticals, Inc.
CORT
Corcept Therapeutics Incorporated
CLDX
Celldex Therapeutics, Inc.
ABEO
Abeona Therapeutics Inc.
CMPS
COMPASS Pathways plc
KYTX
Kyverna Therapeutics, Inc.
LONA
LeonaBio, Inc.
IVA
Inventiva S.A.
AQST
Aquestive Therapeutics, Inc.
ARTV
Artiva Biotherapeutics, Inc.
ZVRA
Zevra Therapeutics, Inc.
PALI
Palisade Bio, Inc.
OBIO
Orchestra BioMed Holdings, Inc.
OCUL
Ocular Therapeutix, Inc.
EYPT
EyePoint Pharmaceuticals, Inc.
IMUX
Immunic, Inc.